Doctor profile · Federal record
Dr. Mark Morginstin, DO
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Philadelphia, PA
- NPI 1124000278
- Accepts Medicare
- 30 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5501 Old York Road, Albert Einstein Medical Center
Philadelphia, PA 19141
(215) 456-3800 - Mailing address
-
101 E Olney Ave, Suite 400
Philadelphia, PA 191202421
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- June 20, 2011
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Pennsylvania #OS011961 · Connecticut #042818
- Medicaid
- PA #101982138
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1124000278. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
869
Distinct HCPCS
5
Medicare allowed
$103,866
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 538 | 284 | $101 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 145 | 78 | $147 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 83 | 80 | $136 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 63 | 63 | $189 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 40 | 29 | $121 |
In context: peer comparison
Among 59 peers in this city , average services per provider: 829. This provider delivers 1.0× the peer median.Open Payments
Industry payments received
All-time total
$70
Transactions
3
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 1 | $26.25 | |
| Daiichi Sankyo Inc. | 1 | $24.76 | |
| Merck Sharp & Dohme LLC | 1 | $19.28 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
765
Patients
163
Total drug cost
$670,717
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 259 | 59 | $4,458 |
| Eliquis (Apixaban) | Brand | 73 | 22 | $52,525 |
| Letrozole | Generic | 65 | 22 | $1,871 |
| Hydroxyurea | Generic | 63 | 17 | $4,062 |
| Exemestane | Generic | 61 | 22 | $7,494 |
| Gabapentin | Generic | 38 | 0 | $482 |
| Xarelto (Rivaroxaban) | Brand | 36 | 0 | $32,564 |
| Acyclovir | Generic | 29 | 0 | $342 |
| Ondansetron Hcl | Generic | 26 | 21 | $326 |
| Oxycodone Hcl | Generic | 23 | 0 | $492 |
Hospital affiliations
Frequently asked questions
What is Dr. Mark Morginstin's medical specialty?
Dr. Mark Morginstin practices Hematology & Oncology Physician in Philadelphia, PA.
Where does Dr. Mark Morginstin practice?
Dr. Mark Morginstin practices at 5501 Old York Road, Philadelphia, PA 19141. Office phone: 2154563800.
What is Dr. Mark Morginstin's NPI?
Dr. Mark Morginstin's National Provider Identifier (NPI) is 1124000278, issued by NPPES.
Does Dr. Mark Morginstin accept Medicare assignment?
Yes. Dr. Mark Morginstin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Morginstin commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Initial hospital care with straightforward or low-level medical decision making (HCPCS 99222). Source: CMS Medicare Physician & Other Practitioners file.